Patent office sends Pfizer “non-final” rejection letter for Lipitor Noven completes JDS purchase, names new board member FDA approves two generics from Glochem Industries NACDS thanks organizations opposed to early implementation of tamper-proof prescriptions FDA cites Novartis for distributing ‘misleading’ promotional card FDA grants tentative approval for Caraco's generic Prandin NACDS chief calls for ‘willing foot soldiers’ in pharmacy’s long campaign for recognition Amgen to reduce expenditures by $1.9 billion and cut staff by 12-14 percent Barr second-quarter earnings show impressive jump from year-ago NACDS joins Rx Response program to coordinate care in times of severe emergency First Previous 2733 2734 2735 2736 2737 Next Last
